1-36097982-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_005202.4(COL8A2):c.1699G>A(p.Gly567Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000777 in 1,605,434 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005202.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL8A2 | NM_005202.4 | c.1699G>A | p.Gly567Ser | missense_variant | 4/4 | ENST00000397799.2 | NP_005193.1 | |
COL8A2 | NM_001294347.2 | c.1504G>A | p.Gly502Ser | missense_variant | 4/4 | NP_001281276.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL8A2 | ENST00000397799.2 | c.1699G>A | p.Gly567Ser | missense_variant | 4/4 | 5 | NM_005202.4 | ENSP00000380901 | P2 | |
COL8A2 | ENST00000481785.1 | c.1504G>A | p.Gly502Ser | missense_variant | 2/2 | 1 | ENSP00000436433 | A2 | ||
COL8A2 | ENST00000303143.9 | c.1699G>A | p.Gly567Ser | missense_variant | 2/2 | 2 | ENSP00000305913 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000795 AC: 121AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000985 AC: 231AN: 234570Hom.: 0 AF XY: 0.000950 AC XY: 122AN XY: 128380
GnomAD4 exome AF: 0.000775 AC: 1126AN: 1453148Hom.: 5 Cov.: 37 AF XY: 0.000797 AC XY: 576AN XY: 722926
GnomAD4 genome AF: 0.000795 AC: 121AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000725 AC XY: 54AN XY: 74466
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 05, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2021 | The c.1699G>A (p.G567S) alteration is located in exon 2 (coding exon 2) of the COL8A2 gene. This alteration results from a G to A substitution at nucleotide position 1699, causing the glycine (G) at amino acid position 567 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at